These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19635670)

  • 1. Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
    Su CR; Yeh SF; Liu CM; Damu AG; Kuo TH; Chiang PC; Bastow KF; Lee KH; Wu TS
    Bioorg Med Chem; 2009 Aug; 17(16):6137-43. PubMed ID: 19635670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 constituents from Clausena excavata: Part II. Carbazoles and a pyranocoumarin.
    Kongkathip B; Kongkathip N; Sunthitikawinsakul A; Napaswat C; Yoosook C
    Phytother Res; 2005 Aug; 19(8):728-31. PubMed ID: 16177980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbazole-pyranocoumarin conjugate and two carbazole alkaloids from the stems of Clausena excavata.
    Chakthong S; Bindulem N; Raknai S; Yodwaree S; Kaewsanee S; Kanjana-Opas A
    Nat Prod Res; 2016 Aug; 30(15):1690-7. PubMed ID: 26824689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines.
    Mao WW; Wang TT; Zeng HP; Wang ZY; Chen JP; Shen JG
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4570-3. PubMed ID: 19616431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
    Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
    J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives.
    Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y
    Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
    Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
    Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.
    Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors.
    Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of halogen-substituted 3-deazaadenosine and 3-deazaguanosine analogues as potential antitumor/antiviral agents.
    Liu MC; Luo MZ; Mozdziesz DE; Lin TS; Dutschman GE; Gullen EA; Cheng YC; Sartorelli AC
    Nucleosides Nucleotides Nucleic Acids; 2001 Dec; 20(12):1975-2000. PubMed ID: 11794802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors.
    Zhao Y; Liu Y; Chen D; Wei Z; Liu W; Gong P
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7230-3. PubMed ID: 21074429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
    Xu ZQ; Pupek K; Suling WJ; Enache L; Flavin MT
    Bioorg Med Chem; 2006 Jul; 14(13):4610-26. PubMed ID: 16513358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.
    Lv Z; Sheng C; Wang T; Zhang Y; Liu J; Feng J; Sun H; Zhong H; Niu C; Li K
    J Med Chem; 2010 Jan; 53(2):660-8. PubMed ID: 20000776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
    Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
    Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY
    Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6,9-triazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Cho J; Kim HM; Park SG; Yoo YA; Kwon JH; Lee H
    Arch Pharm Res; 2008 Aug; 31(8):995-8. PubMed ID: 18787787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.